Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing, WGS), By Product (Platform, Consumables), By Application, By Workflow, By End Use, By Region, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Technology Segment
  • 1.1.2. Product Segment
  • 1.1.3. Workflow Segment
  • 1.1.4. Application Segment
  • 1.1.5. End Use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objective
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
  • 3.4.1. Market Drivers Analysis
    • 3.4.1.1. Decreasing costs for genetic sequencing
    • 3.4.1.2. Development of companion diagnostics and personalized medicine
    • 3.4.1.3. Rising clinical opportunity for NGS technology
    • 3.4.1.4. Technological advancements in cloud computing
  • 3.4.2. Market Restraint Analysis
    • 3.4.2.1. Lack of computational efficiency for data management
    • 3.4.2.2. Non-value-based NGS reimbursement policy and regulation status
    • 3.4.2.3. Challenges associated with NGS implementation
• 3.5. Market Analysis Tools
  • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Technology Business Analysis

• 4.1. Segment Dashboard
• 4.2. Next Generation Sequencing Data Analysis Market: Technology Movement Analysis
• 4.3. Targeted Sequencing & Resequencing
  • 4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 4.3.2. DNA-Based Targeted Sequencing & Resequencing
    • 4.3.2.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.3.3. RNA-Based Targeted Sequencing & Resequencing
    • 4.3.3.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
• 4.4. Whole Genome Sequencing
  • 4.4.1. Whole Genome Sequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 4.5. Whole Exome Sequencing
  • 4.5.1. Whole Exome Sequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

• 5.1. Segment Dashboard
• 5.2. Next Generation Sequencing Data Analysis Market: Product Movement Analysis
• 5.3. Platforms
  • 5.3.1. Platforms Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 5.3.2. Sequencing
    • 5.3.2.1. Sequencing Platforms Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 5.3.3. Data Analysis
    • 5.3.3.1. Data Analysis Platforms Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 5.4. Consumables
  • 5.4.1. Consumables Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 5.4.2. Sample Preparation
    • 5.4.2.1. Sample Preparation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 5.4.3. Target Enrichment
    • 5.4.3.1. Target Enrichment Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Segment Dashboard
• 6.2. Next Generation Sequencing Data Analysis Market: Application Movement Analysis
• 6.3. Oncology
  • 6.3.1. Oncology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.3.2. Diagnostics & Screening
    • 6.3.2.1. Diagnostics & Screening Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 6.3.2.2. Oncology screening
      • 6.3.2.2.1. Oncology Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 6.3.2.2.2. Sporadic Cancer Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 6.3.2.2.3. Inherited Cancer Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.3.2.3. Companion diagnostics
      • 6.3.2.3.1. Companion Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.3.2.4. Other Diagnostics
      • 6.3.2.4.1. Other Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.3.3. Research Studies
    • 6.3.3.1. Research Studies Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 6.4. Clinical Investigation
  • 6.4.1. Clinical Investigation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.4.2. Infectious Diseases
    • 6.4.2.1. Infectious Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.4.3. Idiopathic Diseases
    • 6.4.3.1. Idiopathic Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.4.4. Inherited Diseases
    • 6.4.4.1. Inherited Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.4.5. Non-communicable/other Diseases
    • 6.4.5.1. Reproductive Health Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 6.5. Reproductive Health
  • 6.5.1. Clinical Investigation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.5.2. NIPT
    • 6.5.2.1. NIPT Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.5.2.2. Aneuploidy
      • 6.5.2.2.1. Aneuploidy Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.5.2.3. Microdeletions
      • 6.5.2.3.1. Microdeletions Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.5.3. PGT
    • 6.5.3.1. PGT Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.5.4. Newborn Genetic Screening
    • 6.5.4.1. Newborn Genetic Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.5.5. Single Gene Analysis Market
    • 6.5.5.1. Single Gene Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 6.6. HLA Typing/Immune System Monitoring
  • 6.6.1. HLA Typing/Immune System Monitoring Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 6.7. Metagenomics, Epidemiology & Drug Development
  • 6.7.1. Metagenomics, Epidemiology & Drug Development Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 6.8. Agrigenomics & Forensics
  • 6.8.1. Agrigenomics & Forensics Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 6.9. Consumer Genomics
  • 6.9.1. Consumer Genomics Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 7. Workflow Business Analysis

• 7.1. Segment Dashboard
• 7.2. Next Generation Sequencing Data Analysis Market: Workflow Movement Analysis
• 7.3. Presequencing
  • 7.3.1. Presequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.3.2. Nucleic Acid Extraction
    • 7.3.2.1. Nucleic Acid Extraction Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.3.3. Library Preparation
    • 7.3.3.1. Library Preparation Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 7.4. Sequencing
  • 7.4.1. Sequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 7.5. Data Analysis
  • 7.5.1. Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.5.2. Primary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.5.2.1. Primary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.5.3. Secondary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.5.3.1. Secondary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.5.4. Tertiary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.5.4.1. Tertiary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 8. End Use Business Analysis

• 8.1. Segment Dashboard
• 8.2. Next Generation Sequencing Market: End - Use Movement Analysis
• 8.3. Academic Research
  • 8.3.1. Academic Research Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 8.4. Clinical Research
  • 8.4.1. Clinical Research Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 8.5. Hospitals & Clinics
  • 8.5.1. Hospitals & Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 8.6. Pharmaceutical & Biotech Entities
  • 8.6.1. Pharmaceutical & Biotech Entities Market Estimates and Forecast, 2021 - 2033 (USD Million)
• 8.7. Other Users
  • 8.7.1. Other Users Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 9. Regional Business Analysis

• 9.1. Next Generation Sequencing Market Share By Region, 2024 & 2033
• 9.2. North America
  • 9.2.1. North America next generation sequencing market, 2021 - 2033 (USD Million)
  • 9.2.2. U.S.
    • 9.2.2.1. Key country dynamics
    • 9.2.2.2. U.S. next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.2.3. Target disease prevalence
    • 9.2.2.4. Competitive scenario
    • 9.2.2.5. Regulatory framework
    • 9.2.2.6. Reimbursement scenario
  • 9.2.3. Canada
    • 9.2.3.1. Key country dynamics
    • 9.2.3.2. Canada next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.3.3. Target disease prevalence
    • 9.2.3.4. Competitive scenario
    • 9.2.3.5. Regulatory framework
    • 9.2.3.6. Reimbursement scenario
  • 9.2.4. Mexico
    • 9.2.4.1. Key country dynamics
    • 9.2.4.2. Mexico next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.4.3. Target disease prevalence
    • 9.2.4.4. Competitive scenario
    • 9.2.4.5. Regulatory framework
    • 9.2.4.6. Reimbursement scenario
  • 9.2.5. Europe
  • 9.2.6. Europe Next Generation Sequencing market, 2021 - 2033 (USD Million)
  • 9.2.7. Germany
    • 9.2.7.1. Key country dynamics
    • 9.2.7.2. Germany next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.7.3. Target disease prevalence
    • 9.2.7.4. Competitive scenario
    • 9.2.7.5. Regulatory framework
    • 9.2.7.6. Reimbursement scenario
  • 9.2.8. UK
    • 9.2.8.1. Key country dynamics
    • 9.2.8.2. UK next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.8.3. Target disease prevalence
    • 9.2.8.4. Competitive scenario
    • 9.2.8.5. Regulatory framework
    • 9.2.8.6. Reimbursement scenario
  • 9.2.9. France
    • 9.2.9.1. Key country dynamics
    • 9.2.9.2. France next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.9.3. Target disease prevalence
    • 9.2.9.4. Competitive scenario
    • 9.2.9.5. Regulatory framework
    • 9.2.9.6. Reimbursement scenario
  • 9.2.10. Italy
    • 9.2.10.1. Key country dynamics
    • 9.2.10.2. Italy next generation sequencing (NGS) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.10.3. Target disease prevalence
    • 9.2.10.4. Competitive scenario
    • 9.2.10.5. Regulatory framework
    • 9.2.10.6. Reimbursement scenario
  • 9.2.11. Spain
    • 9.2.11.1. Key country dynamics
    • 9.2.11.2. Spain next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.11.3. Target disease prevalence
    • 9.2.11.4. Competitive scenario
    • 9.2.11.5. Regulatory framework
    • 9.2.11.6. Reimbursement scenario
  • 9.2.12. Denmark
    • 9.2.12.1. Key country dynamics
    • 9.2.12.2. Denmark next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.12.3. Target disease prevalence
    • 9.2.12.4. Competitive scenario
    • 9.2.12.5. Regulatory framework
    • 9.2.12.6. Reimbursement scenario
  • 9.2.13. Sweden
    • 9.2.13.1. Key country dynamics
    • 9.2.13.2. Sweden next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.13.3. Target disease prevalence
    • 9.2.13.4. Competitive scenario
    • 9.2.13.5. Regulatory framework
    • 9.2.13.6. Reimbursement scenario
  • 9.2.14. Norway
    • 9.2.14.1. Key country dynamics
    • 9.2.14.2. Norway next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.2.14.3. Target disease prevalence
    • 9.2.14.4. Competitive scenario
    • 9.2.14.5. Regulatory framework
    • 9.2.14.6. Reimbursement scenario
• 9.3. Asia Pacific
  • 9.3.1. Asia Pacific next generation sequencing market, 2021 - 2033 (USD Million)
  • 9.3.2. Japan
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Japan next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.2.3. Target disease prevalence
    • 9.3.2.4. Competitive scenario
    • 9.3.2.5. Regulatory framework
    • 9.3.2.6. Reimbursement scenario
  • 9.3.3. China
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. China next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.3.3. Target disease prevalence
    • 9.3.3.4. Competitive scenario
    • 9.3.3.5. Regulatory framework
    • 9.3.3.6. Reimbursement scenario
  • 9.3.4. India
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. India next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.4.3. Target disease prevalence
    • 9.3.4.4. Competitive scenario
    • 9.3.4.5. Regulatory framework
    • 9.3.4.6. Reimbursement scenario
  • 9.3.5. South Korea
    • 9.3.5.1. Key country dynamics
    • 9.3.5.2. South Korea next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.5.3. Target disease prevalence
    • 9.3.5.4. Competitive scenario
    • 9.3.5.5. Regulatory framework
    • 9.3.5.6. Reimbursement scenario
  • 9.3.6. Australia
    • 9.3.6.1. Key country dynamics
    • 9.3.6.2. Australia next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.6.3. Target disease prevalence
    • 9.3.6.4. Competitive scenario
    • 9.3.6.5. Regulatory framework
    • 9.3.6.6. Reimbursement scenario
  • 9.3.7. Thailand
    • 9.3.7.1. Key country dynamics
    • 9.3.7.2. Thailand next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.7.3. Target disease prevalence
    • 9.3.7.4. Competitive scenario
    • 9.3.7.5. Regulatory framework
    • 9.3.7.6. Reimbursement scenario
• 9.4. Latin America
  • 9.4.1. Latin America next generation sequencing market, 2021 - 2033 (USD Million)
  • 9.4.2. Brazil
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Brazil next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.2.3. Target disease prevalence
    • 9.4.2.4. Competitive scenario
    • 9.4.2.5. Regulatory framework
    • 9.4.2.6. Reimbursement scenario
  • 9.4.3. Argentina
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Argentina next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.3.3. Target disease prevalence
    • 9.4.3.4. Competitive scenario
    • 9.4.3.5. Regulatory framework
    • 9.4.3.6. Reimbursement scenario
• 9.5. MEA
  • 9.5.1. MEA next generation sequencing market, 2021 - 2033 (USD Million)
  • 9.5.2. South Africa
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. South Africa next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2.3. Target disease prevalence
    • 9.5.2.4. Competitive scenario
    • 9.5.2.5. Regulatory framework
    • 9.5.2.6. Reimbursement scenario
  • 9.5.3. Saudi Arabia
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Saudi Arabia next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3.3. Target disease prevalence
    • 9.5.3.4. Competitive scenario
    • 9.5.3.5. Regulatory framework
    • 9.5.3.6. Reimbursement scenario
  • 9.5.4. UAE
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. UAE next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.4.3. Target disease prevalence
    • 9.5.4.4. Competitive scenario
    • 9.5.4.5. Regulatory framework
    • 9.5.4.6. Reimbursement scenario
  • 9.5.5. Kuwait
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Kuwait next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.5.3. Target disease prevalence
    • 9.5.5.4. Competitive scenario
    • 9.5.5.5. Regulatory framework
    • 9.5.5.6. Reimbursement scenario

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. Illumina
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. F. Hoffman-La Roche Ltd.
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. QIAGEN
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Thermo Fisher Scientific, Inc.
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Bio-Rad Laboratories, Inc.
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Oxford Nanopore Technologies
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Revvity, Inc.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. PacBio
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Merk KGaA
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. BGI
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 North America next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 4 North America next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 5 North America next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 6 North America next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 7 North America next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 8 US next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 9 US next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 10 US next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 11 US next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 12 US next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 13 Canada next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 14 Canada next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 15 Canada next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 16 Canada next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 17 Canada next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 18 Mexico next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 19 Mexico next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 20 Mexico next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 21 Mexico next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 22 Mexico next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 23 Europe next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 24 Europe next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 25 Europe next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 26 Europe next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 27 Europe next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 28 Germany next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 29 Germany next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 30 Germany next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 31 Germany next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 32 Germany next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 33 UK next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 34 UK next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 35 UK next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 36 UK next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 37 UK next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 38 France next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 39 France next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 40 France next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 41 France next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 42 France next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 43 Italy next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 44 Italy next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 45 Italy next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 46 Italy next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 47 Italy next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 48 Spain next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 49 Spain next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 50 Spain next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 51 Spain next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 52 Spain next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 53 Denmark next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 54 Denmark next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 55 Denmark next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 56 Denmark next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 57 Denmark next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 58 Sweden next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 59 Sweden next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 60 Sweden next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 61 Sweden next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 62 Sweden next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 63 Norway next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 64 Norway next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 65 Norway next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 66 Norway next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 67 Norway next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 68 Asia Pacific next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 69 Asia Pacific next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 70 Asia Pacific next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 71 Asia Pacific next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 72 Asia Pacific next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 73 Japan next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 74 Japan next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 75 Japan next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 76 Japan next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 77 Japan next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 78 China next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 79 China next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 80 China next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 81 China next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 82 China next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 83 India next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 84 India next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 85 India next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 86 India next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 87 India next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 88 South Korea next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 89 South Korea next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 90 South Korea next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 91 South Korea next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 92 South Korea next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 93 Australia next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 94 Australia next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 95 Australia next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 96 Australia next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 97 Australia next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 98 Thailand next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 99 Thailand next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 100 Thailand next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 101 Thailand next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 102 Thailand next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 103 Latin America next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 104 Latin America next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 105 Latin America next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 106 Latin America next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 107 Latin America next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 108 Brazil next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 109 Brazil next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 110 Brazil next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 111 Brazil next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 112 Brazil next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 113 Argentina next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 114 Argentina next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 115 Argentina next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 116 Argentina next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 117 Argentina next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 118 Middle East & Africa next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 119 Middle East & Africa next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 120 Middle East & Africa next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 121 Middle East & Africa next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 122 Middle East & Africa next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 123 South Africa next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 124 South Africa next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 125 South Africa next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 126 South Africa next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 127 South Africa next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 128 Saudi Arabia next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 129 Saudi Arabia next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 130 Saudi Arabia next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 131 Saudi Arabia next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 132 Saudi Arabia next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 133 UAE next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 134 UAE next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 135 UAE next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 136 UAE next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 137 UAE next generation sequencing market, by end-use, 2021 - 2033 (USD Million)
• Table 138 Kuwait next generation sequencing market, by technology, 2021 - 2033 (USD Million)
• Table 139 Kuwait next generation sequencing market, by product, 2021 - 2033 (USD Million)
• Table 140 Kuwait next generation sequencing market, by application, 2021 - 2033 (USD Million)
• Table 141 Kuwait next generation sequencing market, by workflow, 2021 - 2033 (USD Million)
• Table 142 Kuwait next generation sequencing market, by end-use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Next Generation Sequencing, Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 13 Porter's Five Forces Analysis
• Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2024
• Fig. 15 Global Next Generation Sequencing Market: Product Movement Analysis
• Fig. 16 Global Next Generation Sequencing Market, for Platforms, 2021 - 2033 (USD Million)
• Fig. 17 Global Next Generation Sequencing Market, for Sequencing, 2021 - 2033 (USD Million)
• Fig. 18 Global Next Generation Sequencing Market, for Data Analysis, 2021 - 2033 (USD Million)
• Fig. 19 Global Next Generation Sequencing Market, for Consumables, 2021 - 2033 (USD Million)
• Fig. 20 Global Next Generation Sequencing Market, for Sample Preparation, 2021 - 2033 (USD Million)
• Fig. 21 Global Next Generation Sequencing Market, for Target Enrichment, 2021 - 2033 (USD Million)
• Fig. 22 Global Next Generation Sequencing Market: Application, Movement Analysis
• Fig. 23 Global Next Generation Sequencing Market, for Oncology, 2021 - 2033 (USD Million)
• Fig. 24 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2021 - 2033 (USD Million)
• Fig. 25 Global Next Generation Sequencing Market, for Screening, 2021 - 2033 (USD Million)
• Fig. 26 Global Next Generation Sequencing Market, for Sporadic Cancer, 2021 - 2033 (USD Million)
• Fig. 27 Global Next Generation Sequencing Market, for Inherited Cancer, 2021 - 2033 (USD Million)
• Fig. 28 Global Next Generation Sequencing Market, for Companion Diagnostics, 2021 - 2033 (USD Million)
• Fig. 29 Global Next Generation Sequencing Market, for Other Diagnostics, 2021 - 2033 (USD Million)
• Fig. 30 Global Next Generation Sequencing Market, for Research Studies, 2021 - 2033 (USD Million)
• Fig. 31 Global Next Generation Sequencing Market, for Clinical Investigation, 2021 - 2033 (USD Million)
• Fig. 32 Global Next Generation Sequencing Market for Infectious Diseases 2021 - 2033 (USD Million)
• Fig. 33 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2021 - 2033 (USD Million)
• Fig. 34 Global Next Generation Sequencing Market, for Inherited Diseases, 2021 - 2033 (USD Million)
• Fig. 35 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2021 - 2033 (USD Million)
• Fig. 36 Global Next Generation Sequencing Market, for Reproductive Health, 2021 - 2033 (USD Million)
• Fig. 37 Global Next Generation Sequencing Market, for NIPT, 2021 - 2033 (USD Million)
• Fig. 38 Global Next Generation Sequencing Market for Aneuploidy, 2021 - 2033 (USD Million)
• Fig. 39 Global Next Generation Sequencing Market, for Microdeletions, 2021 - 2033 (USD Million)
• Fig. 40 Global Next Generation Sequencing Market, for PGT, 2021 - 2033 (USD Million)
• Fig. 41 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2021 - 2033 (USD Million)
• Fig. 42 Global Next Generation Sequencing Market, for Single Gene Analysis, 2021 - 2033 (USD Million)
• Fig. 43 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2021 - 2033 (USD Million)
• Fig. 44 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2021 - 2033 (USD Million)
• Fig. 45 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2021 - 2033 (USD Million)
• Fig. 46 Global Next Generation Sequencing Market, for Consumer Genomics, 2021 - 2033 (USD Million)
• Fig. 47 Global Next Generation Sequencing Market: Technology Movement Analysis
• Fig. 48 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2021 - 2033 (USD Million)
• Fig. 49 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2021 - 2033 (USD Million)
• Fig. 50 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2021 - 2033 (USD Million)
• Fig. 51 Global Next Generation Sequencing Market, for DNA-based, 2021 - 2033 (USD Million)
• Fig. 52 Global Next Generation Sequencing Market for RNA-based, 2021 - 2033 (USD Million)
• Fig. 53 Global Next Generation Sequencing Market: Workflow Movement Analysis
• Fig. 54 Global Next Generation Sequencing Market, for Pre-Sequencing, 2021 - 2033 (USD Million)
• Fig. 55 Global Next Generation Sequencing Market, for Nucleic Acid Extraction, 2021 - 2033 (USD Million)
• Fig. 56 Global Next Generation Sequencing Market for Library Prepartion, 2021 - 2033 (USD Million)
• Fig. 57 Global Next Generation Sequencing Market for Sequencing, 2021 - 2033 (USD Million)
• Fig. 58 Global Next Generation Sequencing Market for NGS Data Analysis, 2021 - 2033 (USD Million)
• Fig. 59 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2021 - 2033 (USD Million)
• Fig. 60 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2021 - 2033 (USD Million)
• Fig. 61 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2021 - 2033 (USD Million)
• Fig. 62 Global Next Generation Sequencing Market: End-use Movement Analysis
• Fig. 63 Global Next Generation Sequencing Market for Academic Research, 2021 - 2033 (USD Million)
• Fig. 64 Global Next Generation Sequencing Market for Clinical Research, 2021 - 2033 (USD Million)
• Fig. 65 Global Next Generation Sequencing Market for Hospitals & Clinics, 2021 - 2033 (USD Million)
• Fig. 66 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2021 - 2033 (USD Million)
• Fig. 67 Global Next Generation Sequencing Market for Other users, 2021 - 2033 (USD Million)
• Fig. 68 Regional Marketplace: Key Takeaways Other users
• Fig. 69 Regional Outlook, 2022 & 2033
• Fig. 70 Global Next Generation Sequencing Market: Region Movement Analysis
• Fig. 71 North America Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 72 U.S. Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 73 Canada Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 74 Mexico Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 75 Europe Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 76 Germany Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 77 UK Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 78 France Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 79 Italy Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 80 Spain Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 81 Denmark Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 82 Sweden Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 83 Norway Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 84 Asia Pacific Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 85 Japan Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 86 China Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 87 India Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 88 South Korea Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 89 Australia Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 90 Thailand Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 91 Latin America Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 92 Brazil Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 93 Argentina Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 94 Middle East and Africa Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 95 South Africa Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 96 Saudi Arabia Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 97 UAE Next Generation Sequencing Market, 2021 - 2033 (USD Million)
• Fig. 98 Kuwait Next Generation Sequencing Market, 2021 - 2033 (USD Million)